Increase in glutamate-induced neurotoxicity by activated astrocytes involves stimulation of protein kinase C

Journal of Neurochemistry

Volumn 82, Issue 3, 2002, Pages 504-515

  Ahlemeyer, Barbara ^a   Kölker, Stefan ^b   Zhu, Yuan ^a   Hoffmann, Georg F ^b   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Glutamate transporter; Hippocampal neurones; NMDA; NR1 NR2A subtype; NR1 NR2B subtype; Phorbol esters

Indexed keywords

CYTARABINE; DIZOCILPINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHORBOL ESTER; PROTEIN KINASE C; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; HIPPOCAMPUS; NERVE CELL; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ASTROCYTES; CELL COUNT; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTARABINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; NEURONS; PROTEIN KINASE C; RATS; RATS, INBRED F344; RECEPTORS, N-METHYL-D-ASPARTATE;

ANIMALIA;

EID: 0036323292     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00994.x     Document Type: Article

References (79)

1. Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal
2. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy
3. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex
4. Astrocytes as mediators of immune and inflammatory responses in the CNS
5. Transport interaction of 1-cystine and 1-glutamate in human diploid fibroblasts in culture
6. Inflammatory mediators and stroke: New opportunities for novel therapeutics
7. Glia modulate NMDA-mediated signaling in primary cultures of cerebellar granule neurons
8. Seizures and brain damage: Are excitatory amino acids involved?
9. Protein kinase C modulation of NMDA currents: An important link for LTP induction
10. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis
11. Role of protein kinase C in glial cell proliferation
12. Potentiation of glutamatergic agonist-induced inositol phosphate formation by basic fibroblast growth factor is related to developmental features in hippocampal cultures: Neuronal survival and glial cell proliferation
13. The glutamate transport inhibitor 1-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical culture
14. Transfer of glutamine between astrocytes and neurons
15. Neurons depend on astrocytes in a coculture system for protection from glutamate toxicity
16. Dependence of neurones on astrocytes in a coculture system renders neurones sensitive to transforming growth factor β1-induced glutamate toxicity
17. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs
18. Many agents that antagonize the NMDA receptorchannel complex in vivo also cause disturbances in motor coordination
19. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism
20. 2+ block of NMDA-receptor channels as a mechanism of modulation
21. Glutamate neurotoxicity and diseases of nervous system
22. Excitotoxic cell death
23. Astrocytes regulate N-methyl-D-aspartate receptor subunit composition increasing neuronal sensitivity to excitotoxicity
24. Isoenzymes of protein kinase C: Differential involvement in apoptosis and pathogenesis
25. Why do neuroprotective drugs work in animals but not humans?
26. Cytosine arabinoside induces apoptosis in cerebellar granule neurons in culture
27. Pathobiology of ischaemic stroke: An integrated view
28. Developmental regulation of tyrosine phosphorylation of the NR2D NMDA glutamate receptor subunit in rat central nervous system
29. Molecular profile of reactive astrocytes - Implications for their role in neurologic disease
30. Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5
31. 2 receptor-mediated proliferative effects on astrocytes in vivo
32. High affinity glutamate transporters: Regulation of expression and activity
33. Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside
34. Glutamine synthetase protects against neuronal degeneration in injured retinal tissue
35. Glialneuronal interaction in Alzheimer's disease: The potential role of a cytokine cycle in disease progression
36. Protein kinase C activation induces tyrosine phosphorylation of the NR2A and NR2B subunits of the NMDA receptor
37. Excitotoxic brain injury suppresses striatal high-affinity glutamate uptake in perinatal rats
38. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain
39. Isoflurane and propofol block neurotoxicity caused by MK-801 in the rat posterior cingulate/retrosplenial cortex
40. Cerebral organic acid disorders induce neuronal damage via excitotoxic organic acids in vitro
41. Potentiation of 3-hydroxyglutarate neurotoxicity following induction of astrocytic iNOS in neonatal rat hippocampal cultures
42. Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons
43. 2-induced apoptosis in CHO cells
44. Microglia: A sensor for pathological events in the CNS
45. The changing landscape of ischaemic brain injury mechanisms
46. Neuritic outgrowth associated with astroglial phenotypic changes induced by antisense glial fibrillary acidic protein (GFAP) mRNA in injured neuron-astrocyte cocultures
47. 3H]GABA
48. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy
49. Excitatory amino acids as a final common pathway for neurologic disorders
50. How protein kinase C activation protects nerve cells from oxidative stress-induced cell death
51. Astrocytes contribute to neuronal impairment in βA toxicity increasing apoptosis in rat hippocampal neurons
52. Phorbol esters and PKC signaling regulate proliferation, vimentin cytoskeleton assembly and glutamine synthethase activity of chick embryo cerebrum astrocytes in culture
53. Activation of protein kinase C suppresses responses to NMDA in rat CA1 hippocampal neurons
54. Cytosine arabinoside kills postmitotic neurons in a fashion resembling trophic factor deprivation: Evidence that a deoxycytidine-dependent process may be required for nerve growth factor signal transduction
55. Enzymatic degradation protects neurons from glutamate excitotoxicity
56. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue
57. Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures
58. Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation
59. GFAP null astrocytes are a favorable substrate for neuronal survival and neurite outgrowth
60. The major tyrosine-phosphorylated protein in the post-synaptic density fraction is N-methyl-D-aspartate receptor subunit 2B
61. Clinical experience with excitatory amino acid antagonist drugs
62. Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: Involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the PI-PLC-calcium pathway
63. Altered protein kinase C activity in different subfields of hippocampus following cerebral ischemia
64. Morphological and biochemical maturation of neurones cultured in the absence of glial cells
65. N-Methyl-D-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies
66. Subtypes of NMDA receptor in neurones cultured from rat brain
67. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanism and cues to physiological function
68. Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor NF-κB
69. Reactive astrocytes: Cellular and molecular cues to biological functions
70. Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture
71. Glutamate release in severe brain ischaemia is mainly by reversed uptake
72. Cytosine arabinoside is neurotoxic to chick embryo spinal cord motoneurons in culture
73. The NMDA receptor complex
74. Role of astrocytes in glutamate homeostasis. Implications for excitotoxicity
75. 3H]glutamate uptake into synaptosomes
76. Expression patterns and regulation of glutamate transporters in the developing and adult nervous system
77. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts
78. Inhibition of the glutamate transporter EAAC1 expressed in xenopus oocytes by phorbol esters
79. Loss of protein kinase C function induces an apoptotic response